Filing Details

Accession Number:
0001140361-11-050027
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-21 16:41:56
Reporting Period:
2011-10-03
Filing Date:
2011-10-21
Accepted Time:
2011-10-21 16:41:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Rexahn Pharmaceuticals Inc. RNN Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1503757 Richard Kivel C/O Rexahn Pharmaceuticals
15245 Shady Grove Road, Suite 455
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-03 2,500 $1.04 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (right-to-buy) $1.25 2021-06-06 20,000 20,000 Direct
Common Stock Stock Options (right-to-buy) $1.19 2011-09-17 2010-09-17 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-06-06 20,000 20,000 Direct
2010-09-17 20,000 20,000 Direct
Footnotes
  1. These options vest and become exercisable in full on June 6, 2012.